Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.
Sansure, a world class diagnostics company, has introduced its latest product developments at MEDICA 2022, Germany, 14-17 November. The Düsseldorf Exhibition centre has held the world’s largest event for the medical sector, which each year brings together industry leaders, global healthcare professionals, and start-ups to explore the latest medical technologies. At Hall 3 J92, Sansure has showcased iPonatic Ⅲ – […]
Let’s Have a Glance at Sansure’s Latest Molecular Diagnostic Products and Solutions! Date: November 14-17, 2022 Time: 10:00 – 18:00 Location: Düsseldorf Exhibition Centre Our Booth: Hall 3J92
One of the leading medical events in the ASEAN region has returned. From 19 to 21 October, the Impact Exhibition Centre in Bangkok hosted Medlab Asia & Asia Health 2022. At this exhibition, which brings over 200 companies from the ASEAN region, Sansure presented a wide selection of molecular diagnostic products. Among the solutions, we showcased testing methods for COVID-19, respiratory tract […]
The 2022 AACC Annual Scientific Meeting and Clinical Lab Expo was held from July 24th to 28th. The exhibition showcased cutting-edge technologies that would shape the future of laboratory medicine. From July 26th to July 28th, Sansure attended the AACC Expo as an international enterprise that leads IVD industry in the world. The AACC Annual Scientific Meeting and Clinical Laboratory […]